Montega Research Update: Buy recommendation reiterated for the Nynomic share with a price target of 50.00 Euro

Wedel (Holst.), 24 June 2021

Montega AG acknowledges the recently announced Novartis order as a further impressive confirmation of Nynomic's performance.

Consequently, the buy recommendation for the Nynomic share is reiterated with the next price target of 50.00 Euro, which corresponds to an upside potential of currently around 20%.

Please find the complete update atwww.nynomic.com/en/analyses/

About Nynomic:

Nynomic AG is an internationally leading manufacturer of products for permanent, non-contact and non-destructive optical measurement technology. The products and services of the Nynomic Group are based on a wide range of intelligent sensors for measuring optical radiation and smart technologies for data acquisition, processing and evaluation. They can be scaled into different application areas and represent high efficiency increase and high customer benefit due to their good adaptability to customer processes. Miniaturization, digitization, automation - Nynomic consistently uses the constant technological change as the basis for above-average growth in the medium term compared to the market. The Nynomic Group has a clear marketing concept as a full-service provider from component to solution. It is globally positioned with independent brands and subsidiaries and around 480 employees.

This is a translation of the original German ad hoc announcement/ corporate press release. Only the original German ad hoc announcement/ corporate press release is binding. No liability is accepted for the correctness of the translation.

More information on the company is available on the corporate website atwww.nynomic.com.

Nynomic AG

Am Marienhof 2

22880 Wedel

Germany

www.nynomic.com

For further inquiries:

Jochen Fischer

FISCHER RELATIONS

Neuer Wall 50

D - 20354 Hamburg
phone: + 49(0)40 822 186 380
fax: + 49(0)40 822 186 450
[e-mail]